Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our previous study of skeletal muscle in a knock-in mouse model of OPMD that expresses Ala17 PABPN1 at native levels (Pabpn1+/A17) showed mild shifts in PAS utilization and reduced poly(A) tail length similar to a hemizygous Pabpn1 knockout mouse, suggesting that alanine expansion may indeed impair PABPN1 function [21].”
In the citing paper
“Though PABPN1 aggregates are a pathologic hallmark of OPMD, they are only detected in 5–10% of myonuclei in limb muscle biopsies from affected individuals [18] and the knock-in mouse model of OPMD [21].”
In the citing paper
“Previous studies using the Pabpn1+/A17 knock-in mouse model of OPMD do not report any changes in steady-state levels of total PABPN1 in murine skeletal muscle but in that model wild type and alanine-expanded PABPN1 are biochemically indistinguishable [21,29].”
In the citing paper
“Our previous studies reported reduced poly(A) tail length in both the Pabpn1+/Ala17 knock-in mouse model of OPMD and in a hemizygous PABPN1 knockout (Pabpn1+/∆) mouse, suggesting that the canonical PABPN1 function of promoting poly(A) polymerase activity is impaired by alanine expansion [21].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031591 · Cited by 5,180
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
Davies, J. E., Sarkar, S., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi422 · Cited by 207
Barrientos, A., Casademont, J., Cardellach, F., Estivill, X., Urbano-Marquez, A., & Nunes, V. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00278-7 · Cited by 149
Research works printed but not linked: 72
- Victor, 1962, Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids, N. Engl. J. Med, 267, 1267, 10.1056/NEJM196212202672501 · doi:10.1056/nejm196212202672501
- Youssof, 2016, The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy, Muscle Nerve, 53, 694, 10.1002/mus.24932 · DOI
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Richard, 2015, PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling, J. Neuromuscul. Dis, 2, 175, 10.3233/JND-140060 · DOI · Paper page
- Jouan, 2014, An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 41, 508, 10.1017/S0317167100018588 · DOI · Paper page
- Kerwitz, 2003, Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA, embo. J, 22, 3705, 10.1093/emboj/cdg347 · DOI
- Kuhn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J. Biol. Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
- Wahle, 1995, Poly(A) tail length control is caused by termination of processive synthesis, J. Biol. Chem, 270, 2800, 10.1074/jbc.270.6.2800 · DOI · Paper page
- Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
- Li, 2015, Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation, PLoS Genet, 11, e1005166., 10.1371/journal.pgen.1005166 · DOI · Paper page
- de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res, 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
- Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
- Fan, 2003, HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 30, 244, 10.1017/S0317167100002675 · DOI
- Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol. Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
- Tavanez, 2009, Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1, PLoS One, 4, e6418., 10.1371/journal.pone.0006418 · DOI
- Apponi, 2013, Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle, Skelet. Muscle, 3, 23., 10.1186/2044-5040-3-23 · DOI · Paper page
- Gidaro, 2013, Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients, J. Neuropathol. Exp. Neurol, 72, 234, 10.1097/NEN.0b013e3182854c07 · DOI
- Uyama, 2000, Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy, Muscle Nerve, 23, 1549, 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0 · DOI
- Dion, 2005, Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice, Neurobiol. Dis, 18, 528, 10.1016/j.nbd.2004.09.021 · DOI
- Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum. Mol. Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
- Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol. Cell. Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
- Davies, 2010, Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy, Sci. Transl. Med, 2, 34ra40., 10.1126/scitranslmed.3000723 · DOI
- Davies, 2008, Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation, Hum. Mol. Genet, 17, 1097, 10.1093/hmg/ddm382 · DOI
- Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat. Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
- Brais, 1995, The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13, Hum. Mol. Genet, 4, 429, 10.1093/hmg/4.3.429 · doi:10.1093/hmg/4.3.429
- Wang, 2006, Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis, Biochem. Biophys. Res. Commun, 340, 815, 10.1016/j.bbrc.2005.12.078 · doi:10.1016/j.bbrc.2005.12.078
- Raz, 2011, Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein, Am. J. Pathol, 179, 1988, 10.1016/j.ajpath.2011.06.044 · DOI · Paper page
- Catoire, 2008, Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1, Hum. Mol. Genet, 17, 2108, 10.1093/hmg/ddn109 · DOI · Paper page
- Chartier, 2006, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, embo J, 25, 2253, 10.1038/sj.emboj.7601117 · DOI · Paper page
- Hino, 2004, Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy, Hum. Mol. Genet, 13, 181, 10.1093/hmg/ddh017 · DOI
- Mankodi, 2012, Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy, Neurobiol. Dis, 45, 539, 10.1016/j.nbd.2011.09.010 · DOI
- Randolph, 2014, Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner, J. Physiol, 592, 5301, 10.1113/jphysiol.2014.280420 · DOI · Paper page
- Anvar, 2013, A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging, Aging (Albany NY), 5, 412, 10.18632/aging.100567 · DOI
- Chartier, 2015, Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis, PLoS Genet, 11, e1005092., 10.1371/journal.pgen.1005092 · DOI
- Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet. Muscle, 1, 15., 10.1186/2044-5040-1-15 · DOI
- Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum. Mol. Genet, 19, 2191, 10.1093/hmg/ddq098 · DOI
- Scheuermann, 2003, Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation, Protein Sci, 12, 2685, 10.1110/ps.03214703 · DOI
- Vest, 2015, An antibody to detect alanine-expanded pabpn1: a new tool to study oculopharyngeal muscular dystrophy, J. Neuromuscul. Dis, 2, 439, 10.3233/JND-150111 · DOI · Paper page
- Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum. Mol. Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
- Banerjee, 2013, PABPN1: molecular function and muscle disease, febs J, 280, 4230, 10.1111/febs.12294 · DOI · Paper page
- Cooper, 1999, In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle, J. Cell. Sci, 112, 2895, 10.1242/jcs.112.17.2895 · DOI · Paper page
- Chekanova, 2001, Analysis of an essential requirement for the poly(A) binding protein function using cross-species complementation, Curr. Biol, 11, 1207, 10.1016/S0960-9822(01)00371-2 · DOI
- Hoque, 2013, Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing, Nat. Methods, 10, 133, 10.1038/nmeth.2288 · DOI · Paper page
- Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc, 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- Huang da, 2009, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res, 37, 1, 10.1093/nar/gkn923 · DOI · Paper page
- Cho, 2016, Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle, faseb J, 30, 674, 10.1096/fj.15-276360 · DOI
- Riaz, 2016, PABPN1-Dependent mRNA Processing Induces Muscle Wasting, PLoS Genet, 12, e1006031., 10.1371/journal.pgen.1006031 · DOI
- Richard, 2017, Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy, Neurology, 88, 359, 10.1212/WNL.0000000000003554 · DOI
- Van Der Sluijs, 2003, Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint, J. Neurol, 250, 1307, 10.1007/s00415-003-0201-6 · doi:10.1007/s00415-003-0201-6
- Youssof, 2015, Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design, Neuromuscul. Disord, 25, 238, 10.1016/j.nmd.2014.11.010 · DOI
- Duddy, 2015, Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia, Skelet. Muscle, 5, 16., 10.1186/s13395-015-0041-y · DOI
- Tanabe, 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol, 69, 91, 10.1007/BF00687043 · DOI · Paper page
- Kelleher, 2015, REDD2 expression in rat skeletal muscle correlates with nutrient-induced activation of mTORC1: responses to aging, immobilization, and remobilization, Am. J. Physiol. Endocrinol. Metab, 308, E122, 10.1152/ajpendo.00341.2014 · DOI
- Miyazaki, 2009, REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch, Am. J. Physiol. Cell. Physiol, 296, C583, 10.1152/ajpcell.00464.2008 · DOI · Paper page
- Klein, 2016, Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing, Nucleic Acids Res, 44, 10929, 10.1093/nar/gkw703 · DOI · Paper page
- Gambelli, 2004, Mitochondrial abnormalities in genetically assessed oculopharyngeal muscular dystrophy, Eur. Neurol, 51, 144, 10.1159/000077070 · doi:10.1159/000077070
- Sadeh, 1993, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Muscle Nerve, 16, 982
- Schroder, 1995, Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type, Neuropathol. Appl. Neurobiol, 21, 68, 10.1111/j.1365-2990.1995.tb01030.x · doi:10.1111/j.1365-2990.1995.tb01030.x
- Wong, 1996, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Neuromuscul. Disord, 6, 163, 10.1016/0960-8966(95)00039-9 · DOI
- Malerba, 2017, PABPN1 gene therapy for oculopharyngeal muscular dystrophy, Nat. Commun, 8, 14848., 10.1038/ncomms14848 · DOI · Paper page
- Kepp, 2016, Alzheimer's disease due to loss of function: A new synthesis of the available data, Prog. Neurobiol, 143, 36, 10.1016/j.pneurobio.2016.06.004 · DOI · Paper page
- Arteaga-Bracho, 2016, Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease, Neurobiol. Dis, 96, 144, 10.1016/j.nbd.2016.09.006 · DOI · Paper page
- Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol. Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
- Kontgen, 1993, Targeted disruption of the MHC class II Aa gene in C57BL/6 mice, Int. Immunol, 5, 957, 10.1093/intimm/5.8.957 · DOI · Paper page
- van der Weyden, 2005, Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector, Genesis, 41, 171, 10.1002/gene.20111 · DOI · Paper page
- Ross, 2011, Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry, J. Vis. Exp, 23, e3266
- Spinazzi, 2012, Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells, Nat. Protoc, 7, 1235, 10.1038/nprot.2012.058 · DOI · Paper page
- Zheng, 2016, 3'READS+, a sensitive and accurate method for 3' end sequencing of polyadenylated RNA, RNA., 22, 1631, 10.1261/rna.057075.116 · DOI
- Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
- Dammer, 2015, Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins, Proteomics., 15, 508, 10.1002/pmic.201400189 · DOI · Paper page
- Smith, 1985, Measurement of protein using bicinchoninic acid, Anal. Biochem, 150, 76, 10.1016/0003-2697(85)90442-7 · DOI · Paper page
- Cox, 2011, Andromeda: a peptide search engine integrated into the MaxQuant environment, J. Proteome Res, 10, 1794, 10.1021/pr101065j · DOI · Paper page
Cited by
Post-transcriptional regulation of gene expression and human disease
Corbett, A. H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.02.011 · Cited by 189
Self-citationMezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Self-citation
Metadata
- Authors
- Vest, K. E., Phillips, B. L., Banerjee, A., Apponi, L. H., Dammer, E. B., Xu, W., Zheng, D., Yu, J., Tian, B., Pavlath, G. K., & Corbett, A. H.
- Affiliations
- Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA
- Department of Biology, Emory University, Atlanta, GA, USA
- Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA
- Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-29
- Volume
- 26
- Issue
- 17
- Pages
- 3235-3252
- ISSN
- 0964-6906
- 1460-2083
- Cited by
- 55
- References
- 5
- Language
- en
- Funders
- National Institutes of Health (5F32AR068207, 1F31AR069994, GM084089, NS069234, NS84870, and AR061987)
- Muscular Dystrophy Association (255856, 157523, 276125, 422006)
- Emory University School of Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology. https://app.cochat.ai/papers/10.1093/hmg/ddx206
- The paper
- Vest, K. E., Phillips, B. L., Banerjee, A., Apponi, L. H., Dammer, E. B., Xu, W., Zheng, D., Yu, J., Tian, B., Pavlath, G. K., & Corbett, A. H. (2017). Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddx206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.